Catalyst Tracker
Genmab A/S GMAB earnings announcement
Genmab A/S exceeded their EPS estimate and fell in line with their revenue estimate, according to their recent quarterly earnings data. Revenue was reported to be $600.44M and EPS was $0.29. For [...]
Read MoreAlnylam Pharmaceuticals ALNY earnings announcement
Alnylam Pharmaceuticals revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. EPS, at -$0.16, was the biggest surprise for the quarter, as it exceeded [...]
Read MoreSensei Biotherapeutics TARA earnings announcement
Protara Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was estimated to be -$0.95 and came in right around that value at -$0.97. Protara Therapeutics' EPS is now below its average [...]
Read MoreVTv Therapeutics ABUS earnings announcement
Arbutus Biopharma Corporation beat their EPS estimate but fell short of their revenue estimate, according to their recent quarterly earnings data. The revenue estimate was $2.15M, but the actual figure was $1.53M. [...]
Read MoreElevation Oncology ELEV earnings announcement
Elevation Oncology revealed their most recent quarterly earnings data, in which EPS ended up lower than estimates. EPS was reported to be -$0.23, which fell short of the estimated value of -$0.20.
Closing [...]
Read MoreGeron Corporation GERN earnings announcement
Geron Corporation revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. Revenue, at $304k, was the biggest surprise for the quarter, as it exceeded [...]
Read MoreSensei Biotherapeutics BCYC earnings announcement
Bicycle Therapeutics plc revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. EPS was estimated to be -$1.24 and the actual figure came in at [...]
Read MoreBlueprint Medicines Corporation BPMC earnings announcement
Blueprint Medicines Corporation revealed their most recent quarterly earnings data, in which both revenue and EPS ended up higher than estimates. The revenue estimate was $80.43M, but the actual figure was $96.12M. Blueprint Medicines [...]
Read MoreVTv Therapeutics KYMR earnings announcement
Kymera Therapeutics revealed their most recent quarterly earnings data for Q1. EPS was -$0.69, exceeding estimates by 5.48%. For EPS, that is $0.01 (+1.43%) higher than it was this time last year.
Kymera Therapeutics [...]
Read MoreSensei Biotherapeutics AGIO earnings announcement
Agios Pharmaceuticals beat their EPS estimate and fell in line with their revenue estimate, according to their recent quarterly earnings data. EPS was estimated to be -$1.65 and the actual figure came [...]
Read MoreSensei Biotherapeutics REGN earnings announcement
Regeneron Pharmaceuticals fell in line with their revenue estimate but fell short of their EPS estimate, according to their recent quarterly earnings data. Revenue was reported to be $3.15B and EPS was [...]
Read More